Pan‐cancer analysis of altered glycosyltransferases confers poor clinical outcomes is a research paper published in Clinical and Translational Discovery (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01 CA217798
National Cancer Institute
Grant: R01CA206444
National Cancer Institute
Grant: R01CA210637
National Cancer Institute
Grant: R01CA228524
NCI NIH HHS
Grant: R01 CA195586
National Institutes of Health
Grant: 1R01CA228524-01
Targeting CXCR2 axis in Pancreatic Cancer
National Institutes of Health
Grant: 5R01CA206444-03
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer
National Institutes of Health
Grant: 5R01CA210637-02
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia
National Institutes of Health
Grant: 5P01CA217798-04
Pancreatic Cancer Metastasis
National Institutes of Health
U.S. Department of Health and Human Services
FWCI
0.31
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals